2011 Annual Meeting | Diagnostic Dilemmas in Multiple Sclerosis

Date Monday 04/11/11

Time 09:00 AM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Mark Keegan, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the broad spectrum of CNS demyelinating diseases, inflammatory, other myelopathies, and the differential diagnosis of mimickers of these conditions.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
09:00 AM - 09:40 AM		Spectrum of CNS Inflammatory Demyelinating Disorders Mark Keegan, MD, FAAN
09:40 AM - 10:20 AM		Diagnostic Challenges in Pediatric CNS Demyelinating Disease Brenda L. Banwell, MD, FAAN
10:20 AM - 10:30 AM		Questions and Answers
10:30 AM - 10:45 AM		Break
10:45 AM - 11:25 AM		Diagnostic Approach to Acute and Subacute Myelopathy Brian G. Weinshenker, MD, FAAN
11:25 AM - 12:05 PM		Rational Approach to Mimickers of Multiple Sclerosis Mark Keegan, MD, FAAN
12:05 PM - 12:40 PM		Case Discussions
12:40 PM - 01:00 PM		Questions and Answers

Faculty Disclosures
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��